Spots Global Cancer Trial Database for cancer of the ovary
Every month we try and update this database with for cancer of the ovary cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer | NCT02582931 | Cancer of Ovary Cancer of the O... Neoplasms, Ovar... Ovarian Cancer Ovary Cancer Ovary Neoplasms | MRI-guided SBRT EORTC QLQ-C30 Q... EORTC QLQ-OV28 ... | 18 Years - | Washington University School of Medicine | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| Blood Collection From People With Ovarian Cancer | NCT02063464 | Ovarian Cancer Cancer of the O... Ovarian Neoplas... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer | NCT03281681 | Ovarian Cancer | VAL-083, Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
| Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer | NCT01650376 | Stage III Ovari... Stage IV Ovaria... Uterine Cancer | Olaparib Carboplatin Paclitaxel | 18 Years - | Swedish Medical Center | |
| NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer | NCT03146663 | Ovarian Cancer | NUC-1031 500 mg NUC-1031 750mg | 18 Years - | NuCana plc | |
| Cancer Loyalty Card Study | NCT03994653 | Ovarian Neoplas... | Risk Factor Que... Clinical Questi... | 18 Years - | Imperial College London | |
| Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer | NCT05059782 | Ovarian Cancer Neoplasm, Ovari... Ovarian Neoplas... Ovary Neoplasms Neoplasm, Ovary Neoplasms, Ovar... Ovary Neoplasm Neoplasms, Ovar... Ovary Cancer Cancer, Ovarian... Cancers, Ovary Ovary Cancers Cancer, Ovarian Cancers, Ovaria... Ovarian Cancers Cancer of Ovary Cancer of the O... | chemotherapy, t... IFRT, IMRT or S... | 18 Years - | Health Science Center of Xi'an Jiaotong University | |
| A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer | NCT03281681 | Ovarian Cancer | VAL-083, Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
| Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines | NCT02432378 | Cancer of Ovary Cancer of the O... Neoplasms, Ovar... Ovarian Cancer Ovary Cancer Ovary Neoplasms | Cisplatin + cel... Cisplatin + CKM... | 18 Years - | Roswell Park Cancer Institute | |
| Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer | NCT00327171 | Neoplasms Cancer of the O... | Aflibercept (zi... Aflibercept (zi... | 18 Years - | Sanofi | |
| A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer | NCT03281681 | Ovarian Cancer | VAL-083, Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer | NCT03281681 | Ovarian Cancer | VAL-083, Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
| Weekly Topotecan Therapy in Patients With Ovarian Cancer | NCT00194935 | Ovarian Cancer | Topotecan | 18 Years - | Weill Medical College of Cornell University | |
| Weekly Topotecan Therapy in Patients With Ovarian Cancer | NCT00194935 | Ovarian Cancer | Topotecan | 18 Years - | Weill Medical College of Cornell University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
